JEJuan Luis Escobar-Ramírez

Juan Luis Escobar-Ramírez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Juan Luis Escobar-Ramírez has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Predicting the Toxicity In Silico of the Aqueous Extract of Chiranthodendron pentadactylon Flowers. Experimental Evaluation In Vivo

    by Oscar Salvador Barrera-Vázquez, Gil Alfonso Magos-Guerrero, Juan Luis Escobar-Ramírez, Rubén San Miguel-Chávez, Maira Huerta-Reyes

    Chiranthodendron pentadactylon Larreat (“flor de manita”) is traditionally used for gastrointestinal, cardiovascular, and neurological disorders. Objective: This study comprehensively integrated phytochemical characterization, in silico toxicological profiling, an exposure-informed Integrative Toxicity Prediction Model (ITPM), uncertainty analysis, and acute testing of a fresh flower aqueous extract (FFAE). Methods: Thirty-six phytochemicals were screened for hepatotoxicity, nephrotoxicity, Ames mutagenicity, carcinogenicity, hERG inhibition, reproductive-effects alerts, and acute oral toxicity. Five organ- or effect-specific endpoints were integrated into an exploratory Toxicological Alert Score (TAS), whereas reproductive alerts and predicted LD50 were reported separately. Seventeen compounds quantified in the FFAE were compared with a 20-compound literature-informed profile through 50,000 Monte Carlo iterations. Male CD-1 mice received a single FFAE dose of 300–5000 mg/kg and were observed for 14 days. Results: Positive predictions occurred for hERG inhibition in 33 compounds (91.7%), hepatotoxicity in 29 (80.6%), nephrotoxicity and carcinogenicity in 28 each (77.8%), and mutagenicity in 21 (58.3%). Six compounds had predicted LD50 values ≤ 1000 mg/kg. The proportional ITPM toxicity-evidence index was 6.91% for the experimental profile and 19.34% for the literature-informed profile. Monte Carlo means were 6.98% (95% uncertainty interval, 5.65–8.44%) and 19.32% (16.76–22.37%), respectively. No mortality, overt clinical signs, or treatment-related body weight differences occurred up to 5000 mg/kg. Conclusions: Compound-level predictions identified priorities for confirmatory testing, while the extract-specific model yielded a lower comparative toxicity-evidence proportion, and the animal study showed low overall acute toxicity under the evaluated conditions. These findings do not establish general or long-term safety, calibrated risk probabilities, or biological neutralization of toxicological liabilities.

  • Open Access

    Predicting the Toxicity In Silico of the Aqueous Extract of Chiranthodendron pentadactylon Flowers. Experimental Evaluation In Vivo

    by Oscar Salvador Barrera-Vázquez, Gil Alfonso Magos-Guerrero, Juan Luis Escobar-Ramírez, Maira Huerta-Reyes

    Chirantodendron pentadactylon L., known in Mexico City as “flor de manita”, is a plant native to Mexico that is used traditionally in gastrointestinal, cardiovascular, and neurological diseases. This study looked at its potential toxicity using computer models and animal testing. Many people believe that “natural” means “safe,” but this can lead to unregulated use and health risks because some compounds can be toxic. Using computer-based toxicology, researchers analyzed thirty-eight compounds from the flowers of Ch. pentadactylon. They found that 65.8% of the compounds were potentially harmful to the liver, 63.1% mutagenic, 63.5% carcinogenic, 7.8% posed risks to the heart, and 15.7% could affect reproduction. However, 84.2% of these compounds had predicted lethal doses (LD₅₀) greater than 1000 mg/kg. In tests on CD1 mice using water extracts, there were no signs of toxicity or death at doses up to 5000 mg/kg. The Integrative Toxicity Prediction Model suggests that the dried water extract (AEDF) is safe, with a protection value of 0.5332 compared to a toxicity value of 0.0395. This resulted in a safety-to-risk ratio of 13.5. A further analysis estimated a 38.45% chance of toxicity and a 61.55% chance of non-toxicity, placing the extract in a low-risk category for toxicity. These findings suggest that predicting toxicity from single ingredients might overstate the dangers of using combined plant materials. The safety of this plant appears to come from the high levels of beneficial compounds that protect against toxic effects. More long-term studies are needed to check for any cumulative risks.

  • Open Access

    Discovering Potential Compounds for Venous Disease Treatment through Virtual Screening and Network Pharmacology Approach

    by Oscar Salvador Barrera-Vázquez, Juan Luis Escobar-Ramírez, Jacinto Santiago-Mejía, Omar Francisco Carrasco-Ortega, Gil Alfonso Magos-Guerrero

    Peripheral venous hypertension has emerged as a prominent characteristic of venous disease (VD). This disease causes lower limb edema due to impaired blood transport in the veins. The phlebotonic drugs in use showed moderate evidence for reducing edema slightly in the lower legs and little or no difference in the quality of life. To enhance the probability of favorable experimental results, a virtual screening procedure was employed to identify molecules with potential therapeutic activity in VD. Compounds obtained from multiple databases, namely AC Discovery, NuBBE, BIOFACQUIM, and InflamNat, were compared with reference compounds. The examination of structural similarity, targets, and signaling pathways in venous diseases allows for the identification of compounds with potential usefulness in VD. The computational tools employed were rcdk and chemminer from R-Studio and Cytoscape. An extended fingerprint analysis allowed us to obtain 1846 from 41,655 compounds compiled. Only 229 compounds showed pharmacological targets in the PubChem server, of which 84 molecules interacted with the VD network. Because of their descriptors and multi-target capacity, only 18 molecules of 84 were identified as potential candidates for experimental evaluation. We opted to evaluate the berberine compound because of its affordability, and extensive literature support. The experiment showed the proposed activity in an acute venous hypertension model.


  • Open Access

    The Hypotensive and Vasodilatory Effects Observed in Rats Exposed to Chiranthodendron pentadactylon Larreat Flowers Can Be Attributed to Cyanidin 3-O-Glucoside

    by Juan Luis Escobar-Ramírez, Jacinto Santiago-Mejía, Maribel Soto-Núñez, Oscar Salvador Barrera-Vázquez, Roberto Vargas-Querea, Gil Alfonso Magos-Guerrero

    Chiranthodendron pentadactylon Larreat is a tree native to southeastern Mexico and Guatemala. Its flower is used in Mexican folk medicine to treat a variety of diseases, including conditions of blood pressure. However, scientific information on its usefulness in this pathology is lacking. The present study evaluates the effect of a methanolic extract (ME) from the flower and its active constituents on heart rate (HR) and mean arterial pressure (MAP) in anesthetized rats (MAPHR). The study also analyzed the effects on rat-isolated aortic rings (RIAR) and the rat mesenteric arterial bed (MABR). Active fractions were chromatographed, which led to the isolation of cyanidin 3-O-glucoside (C3G) identified through HPLC. The Chiranthodendron pentadactylon flowers produced hypotensive and vasorelaxant effects associated with C3G. The vasorelaxant effect is a mechanism underlying the synthesis and release of nitric oxide (NO). Neither cholinergic receptors nor prostaglandins are involved. ME and C3G cause cardiovascular depression in anesthetized rats via cholinergic and prostanoid mechanisms. Our research expands the scientific understanding of the flowers on the rat cardiovascular system. This amplifies the appreciation of the flower’s ethnomedicine employed to control blood pressure. However, researchers need to conduct toxicity studies to determine the safety of this plant.